Publications by authors named "Pache L"

Antigenically distinct SARS-CoV-2 variants increase the reinfection risk for vaccinated and previously exposed population due to antibody neutralization escape. COVID-19 severity depends on many variables, including host immune responses, which differ depending on genetic predisposition. To address this, we perform immune profiling of female mice with different genetic backgrounds -transgenic K18-hACE2 and wild-type 129S1- infected with the severe B.

View Article and Find Full Text PDF

Defining the subset of cellular factors governing SARS-CoV-2 replication can provide critical insights into viral pathogenesis and identify targets for host-directed antiviral therapies. While a number of genetic screens have previously reported SARS-CoV-2 host dependency factors, these approaches relied on utilizing pooled genome-scale CRISPR libraries, which are biased towards the discovery of host proteins impacting early stages of viral replication. To identify host factors involved throughout the SARS-CoV-2 infectious cycle, we conducted an arrayed genome-scale siRNA screen.

View Article and Find Full Text PDF

Many machine learning applications in bioinformatics currently rely on matching gene identities when analyzing input gene signatures and fail to take advantage of preexisting knowledge about gene functions. To further enable comparative analysis of OMICS datasets, including target deconvolution and mechanism of action studies, we develop an approach that represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We develop the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model and demonstrate that its application to the Broad Institute's L1000 datasets results in more effective compound-target predictions than models based on gene identities alone.

View Article and Find Full Text PDF

Hybrid immunity (vaccination + natural infection) to SARS-CoV-2 provides superior protection to re-infection. We performed immune profiling studies during breakthrough infections in mRNA-vaccinated hamsters to evaluate hybrid immunity induction. The mRNA vaccine, BNT162b2, was dosed to induce binding antibody titers against ancestral spike, but inefficient serum virus neutralization of ancestral SARS-CoV-2 or variants of concern (VoCs).

View Article and Find Full Text PDF

Antiretroviral therapy (ART) has brought the HIV/AIDS epidemic under control, but a curative strategy for viral eradication is still needed. The cessation of ART results in rapid viral rebound from latently infected CD4+ T cells, showing that control of viral replication alone does not fully restore immune function, nor does it eradicate viral reservoirs. With a better understanding of factors and mechanisms that promote viral latency, current approaches are primarily focused on the permanent silencing of latently infected cells ("block and lock") or reactivating HIV-1 gene expression in latently infected cells, in combination with immune restoration strategies to eliminate HIV infected cells from the host ("shock and kill").

View Article and Find Full Text PDF
Article Synopsis
  • * Disease severity in COVID-19 is influenced by factors like age, pre-existing health conditions, and genetic differences, affecting how the immune system responds to the virus.
  • * Research using different mice models showed that prior BA.1 infection could protect some mice from severe B.1.351 reinfection while worsening outcomes in others, based on their genetic background and immune response characteristics.
View Article and Find Full Text PDF

Influenza A Virus (IAV) is a recurring respiratory virus with limited availability of antiviral therapies. Understanding host proteins essential for IAV infection can identify targets for alternative host-directed therapies (HDTs). Using affinity purification-mass spectrometry and global phosphoproteomic and protein abundance analyses using three IAV strains (pH1N1, H3N2, H5N1) in three human cell types (A549, NHBE, THP-1), we map 332 IAV-human protein-protein interactions and identify 13 IAV-modulated kinases.

View Article and Find Full Text PDF

Hybrid immunity to SARS-CoV-2 provides superior protection to re-infection. We performed immune profiling studies during breakthrough infections in mRNA-vaccinated hamsters to evaluate hybrid immunity induction. mRNA vaccine, BNT162b2, was dosed to induce binding antibody titers against ancestral spike, but inefficient serum virus neutralization of ancestral SARS-CoV-2 or variants of concern (VoCs).

View Article and Find Full Text PDF
Article Synopsis
  • - Biomedical datasets are growing, facing challenges in being findable, accessible, interoperable, and reusable (FAIR), as many repositories lack adherence to a single metadata standard.
  • - A consortium of infectious disease researchers developed a reusable metadata schema based on Schema.org to improve data discoverability and reusability, successfully cataloging nearly 400 datasets and tools.
  • - The new approach enhances data discovery and supports open science practices, while ongoing challenges with FAIRness still need to be addressed beyond just discoverability.
View Article and Find Full Text PDF

Molecular responses to influenza A virus (IAV) infections vary between mammalian species. To identify conserved and species-specific molecular responses, we perform a comparative study of transcriptomic data derived from blood cells, primary epithelial cells, and lung tissues collected from IAV-infected humans, ferrets, and mice. The molecular responses in the human host have unique functions such as antigen processing that are not observed in mice or ferrets.

View Article and Find Full Text PDF
Article Synopsis
  • * Apra S4 effectively prevents the replication of several viruses, including SARS-CoV-2 and influenza A, demonstrating significant antiviral effects in human cells at very low concentrations.
  • * The drug works by disrupting key processes in the viral life cycle, including the creation of structures necessary for viral replication and the production of essential viral proteins, making further research on Sec61 inhibitors promising for antiviral therapy.
View Article and Find Full Text PDF

The HIV-1 accessory protein Vpu modulates membrane protein trafficking and degradation to provide evasion of immune surveillance. Targets of Vpu include CD4, HLAs, and BST-2. Several cellular pathways co-opted by Vpu have been identified, but the picture of Vpu's itinerary and activities within membrane systems remains incomplete.

View Article and Find Full Text PDF
Article Synopsis
  • The fate of influenza A virus (IAV) in host cells is determined by the interplay between the cell's defense systems and the virus's strategies to evade those defenses.
  • A comprehensive analysis combining genetic screens, transcriptomics, and proteomics identified key cell mechanisms, particularly the role of autophagy regulator TBC1D5, in inhibiting IAV replication.
  • The IAV M2 protein impedes TBC1D5's function by disrupting its interaction with Rab7, allowing the virus to avoid degradation and continue its replication and spread.
View Article and Find Full Text PDF

A deficient interferon (IFN) response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been implicated as a determinant of severe coronavirus disease 2019 (COVID-19). To identify the molecular effectors that govern IFN control of SARS-CoV-2 infection, we conducted a large-scale gain-of-function analysis that evaluated the impact of human IFN-stimulated genes (ISGs) on viral replication. A limited subset of ISGs were found to control viral infection, including endosomal factors inhibiting viral entry, RNA binding proteins suppressing viral RNA synthesis, and a highly enriched cluster of endoplasmic reticulum (ER)/Golgi-resident ISGs inhibiting viral assembly/egress.

View Article and Find Full Text PDF
Article Synopsis
  • Clofazimine, an anti-leprosy drug approved by the FDA, shows promise in inhibiting various coronaviruses, including SARS-CoV-2 and MERS-CoV, by interfering with viral replication and cell fusion.
  • In studies with hamsters and in combination with remdesivir, clofazimine reduced viral loads and shedding while alleviating inflammation, making it a potential low-cost treatment option for COVID-19, especially in resource-limited settings.
View Article and Find Full Text PDF

"Shock and kill" strategies focus on purging the latent HIV-1 reservoir by treating infected individuals with therapeutics that activate the latent virus and subsequently eliminating infected cells. We have previously reported that induction of non-canonical nuclear factor κB (NF-κB) signaling through a class of small-molecule antagonists known as Smac mimetics can reverse HIV-1 latency. Here, we describe the development of Ciapavir (SBI-0953294), a molecule specifically optimized for HIV-1 latency reversal that was found to be more efficacious as a latency-reversing agent than other Smac mimetics under clinical development for cancer.

View Article and Find Full Text PDF

COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) since 2012. Treatment options for CoVs are largely lacking. Here, we show that clofazimine, an anti-leprosy drug with a favorable safety and pharmacokinetics profile, possesses pan-coronaviral inhibitory activity, and can antagonize SARS-CoV-2 replication in multiple systems, including the human embryonic stem cell-derived cardiomyocytes and lung cultures.

View Article and Find Full Text PDF

A deficient interferon response to SARS-CoV-2 infection has been implicated as a determinant of severe COVID-19. To identify the molecular effectors that govern interferon control of SARS-CoV-2 infection, we conducted a large-scale gain-of-function analysis that evaluated the impact of human interferon stimulated genes (ISGs) on viral replication. A limited subset of ISGs were found to control viral infection, including endosomal factors that inhibited viral entry, nucleic acid binding proteins that suppressed viral RNA synthesis, and a highly enriched cluster of ER and Golgi-resident ISGs that inhibited viral translation and egress.

View Article and Find Full Text PDF

The infectious life cycle of the human immunodeficiency virus type 1 (HIV-1) is characterized by an ongoing battle between a compendium of cellular proteins that either promote or oppose viral replication. On the one hand, HIV-1 utilizes dependency factors to support and sustain infection and complete the viral life cycle. On the other hand, both inducible and constitutively expressed host factors mediate efficient and functionally diverse antiviral processes that counteract an infection.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic, caused by the SARS-CoV-2 virus, emerged in 2019, and while developing a vaccine typically takes 12-18 months, finding immediate treatments is critical.
  • Researchers screened about 12,000 existing FDA-approved drugs to find 100 molecules that can inhibit the replication of SARS-CoV-2, with 21 showing promising dose-response effects.
  • Among the identified drugs, 13 have effective concentrations that could be used safely in patients, including notable candidates like apilimod and MDL-28170, which also showed effectiveness in lab models simulating human lung cells.
View Article and Find Full Text PDF

The emergence of novel SARS coronavirus 2 (SARS-CoV-2) in 2019 has triggered an ongoing global pandemic of severe pneumonia-like disease designated as coronavirus disease 2019 (COVID-19). To date, more than 2.1 million confirmed cases and 139,500 deaths have been reported worldwide, and there are currently no medical countermeasures available to prevent or treat the disease.

View Article and Find Full Text PDF

A critical component in the interpretation of systems-level studies is the inference of enriched biological pathways and protein complexes contained within OMICs datasets. Successful analysis requires the integration of a broad set of current biological databases and the application of a robust analytical pipeline to produce readily interpretable results. Metascape is a web-based portal designed to provide a comprehensive gene list annotation and analysis resource for experimental biologists.

View Article and Find Full Text PDF

Many viral pathogens target innate sensing cascades and/or cellular transcription factors to suppress antiviral immune responses. Here, we show that the accessory viral protein U (Vpu) of HIV-1 exerts broad immunosuppressive effects by inhibiting activation of the transcription factor NF-κB. Global transcriptional profiling of infected CD4 +T cells revealed that -deficient HIV-1 strains induce substantially stronger immune responses than the respective wild type viruses.

View Article and Find Full Text PDF